Table 1.
Demographic and clinical characteristics of the sample.
| Demographic Variables | Clinical Variables | Current Pharmacotherapies | |||
|---|---|---|---|---|---|
| Variables | N/Mean (%/SD) | Variables | N/Mean (%/SD) | Variables | N (%) |
| Age (years) | 40.31 (12.67) | Diagnosis | Adjunctive Treatment | 64 (91.42) | |
| Gender (female) | 45 (64.30) | MDD BD |
39 (55.71) 31 (44.29) |
Antidepressants | 48 (68.57) |
| Education (college graduate) | 41 (55.57) | Severity | Antipsychotics | 41 (58.57) | |
| Occupational status (employed) | 16 (22.86) | Baseline MADRS | 33.6 (6.32) | Lithium | 30 (42.85) |
| Maudslay * | 11.09 (2.03) | Anticonvulsants | 37 (52.85) | ||
| Anxiety Disorder | 31 (44.29) | Benzodiazepines | 26 (37.14) | ||
| BMI | 29.1 (7.5) | ||||
| Clinical Comorbidity | 57 (81.42) | ||||
| Obesity | 24 (34.29) | ||||
| Hypertension | 12 (17.14) | ||||
* MSM the Maudslay Staging Method.